ribavirin has been researched along with Carcinoma, Bronchogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narayanan, VL; Paull, KD; Plowman, J; Robins, RK; Srivastava, PC | 1 |
| Carr, DT; Dhingra, HM; Glisson, BS; Holoye, PY; Jeffries, D; Lee, JS; Murphy, WK; Umsawasdi, T | 1 |
2 other study(ies) available for ribavirin and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
Topics: Animals; Antineoplastic Agents; Carcinoma, Bronchogenic; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Ribavirin; Ribonucleosides | 1982 |
Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ribavirin; Ribonucleosides | 1988 |